apg-2449
ascentage pharmaceuticals
['ascent', 'sclc', 'nsclc', 'apg-2449 ', 'ascentage pharma', 'ascentage']
dcbn news: asco 2022 | ascentage pharma releases for the first time results of its fak/alk/ros1 inhibitor apg-2449 demonstrating safety and efficacy in patients with advanced nsclc: suzhou, china, and ... #biotech #news 
Life science news and jobs from Washington DC, Maryland and Virginia. Part of @BiotechNetworks, connecting #biotech since 2008.